Clinical Cancer Research The Science of Cancer Health Disparities Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magklara, A.
Right arrow Articles by Diamandis, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magklara, A.
Right arrow Articles by Diamandis, E. P.
Clinical Cancer Research Vol. 7, 806-811, April 2001
© 2001 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

The Human KLK8 (Neuropsin/Ovasin) Gene

Identification of Two Novel Splice Variants and Its Prognostic Value in Ovarian Cancer

Angeliki Magklara, Andreas Scorilas, Dionyssios Katsaros, Marco Massobrio, George M. Yousef, Stefano Fracchioli, Saverio Danese and Eleftherios P. Diamandis1

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 1X5 Canada [A. M., A. S., G. M. Y., E. P. D.], and Departments of Obstetrics and Gynecology, Gynecologic Oncology Unit [D. K., M. M., S. F.] and Gynecology, S. Anna Hospital [S. D.], University of Turin, Turin 10126, Italy

KLK8 (neuropsin/ovasin) is a new member of the human kallikrein gene family, which consists of enzymes with serine protease enzymatic activity. Recent reports have implicated KLK8 in ovarian cancer. KLK8 may have potential clinical value for disease diagnosis or prognosis and it may also be a useful therapeutic target.

Purpose: We undertook this study to evaluate the prognostic value of KLK8 in ovarian carcinoma by examining its expression in ovarian tumors.

Experimental Design: The KLK8 gene was analyzed by reverse transcription-PCR and direct sequencing in several human normal tissues. Subsequently, its expression was studied in a set of ovarian tumors, and statistical analysis was performed.

Results: We have identified two novel mRNA splice variants of the KLK8 gene, which are abundantly expressed in many tissues. These new variants were named KLK8 type 3 and type 4. Study of the expression of the KLK8 gene and its spliced variants in ovarian tumors indicated that the new variants were expressed very frequently and that full-length KLK8 expression is an independent and favorable prognostic marker for ovarian cancer. Patients with higher KLK8 expression in the tumor have lower grade disease, lower residual tumor left after surgery, live longer, and relapse less frequently. In multivariate analysis, higher KLK8 expression was significantly associated with longer disease-free survival.

Conclusions: These results suggest that KLK8 is a novel, favorable prognostic marker in ovarian cancer. Because KLK8 encodes for a predicted secreted protein, its detection in serum may aid in ovarian cancer diagnosis.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
A. B. Tchagang, A. H. Tewfik, M. S. DeRycke, K. M. Skubitz, and A. P.N. Skubitz
Early detection of ovarian cancer using group biomarkers
Mol. Cancer Ther., January 1, 2008; 7(1): 27 - 37.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Zheng, D. Katsaros, S. J.C. Shan, I. R. de la Longrais, M. Porpiglia, A. Scorilas, N. W. Kim, R. L. Wolfert, I. Simon, L. Li, et al.
A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy
Clin. Cancer Res., December 1, 2007; 13(23): 6984 - 6992.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-P. Sher, C.-C. Chou, R.-H. Chou, H.-M. Wu, W.-S. Wayne Chang, C.-H. Chen, P.-C. Yang, C.-W. Wu, C.-L. Yu, and K. Peck
Human Kallikrein 8 Protease Confers a Favorable Clinical Outcome in Non-Small Cell Lung Cancer by Suppressing Tumor Cell Invasiveness
Cancer Res., December 15, 2006; 66(24): 11763 - 11770.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M.R. Darling, L. Jackson-Boeters, T.D. Daley, and E.P. Diamandis
Human Kallikrein 6 Expression in Salivary Gland Tumors
J. Histochem. Cytochem., March 1, 2006; 54(3): 337 - 342.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. A. Borgono, T. Kishi, A. Scorilas, N. Harbeck, J. Dorn, B. Schmalfeldt, M. Schmitt, and E. P. Diamandis
Human Kallikrein 8 Protein Is a Favorable Prognostic Marker in Ovarian Cancer
Clin. Cancer Res., March 1, 2006; 12(5): 1487 - 1493.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
Y Dong, L T Bui, D M Odorico, O L Tan, S A Myers, H Samaratunga, R A Gardiner, and J A Clements
Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms
Endocr. Relat. Cancer, December 1, 2005; 12(4): 875 - 889.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. D. Santin, E. P. Diamandis, S. Bellone, A. Soosaipillai, S. Cane, M. Palmieri, A. Burnett, J. J. Roman, and S. Pecorelli
Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer
Clin. Cancer Res., May 1, 2005; 11(9): 3320 - 3325.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. A. Borgono, I. P. Michael, and E. P. Diamandis
Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer
Mol. Cancer Res., May 1, 2004; 2(5): 257 - 280.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Shigemasa, L. Gu, H. Tanimoto, T. J. O'Brien, and K. Ohama
Human Kallikrein Gene 11 (KLK11) mRNA Overexpression Is Associated with Poor Prognosis in Patients with Epithelial Ovarian Cancer
Clin. Cancer Res., April 15, 2004; 10(8): 2766 - 2770.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Scorilas, C. A. Borgono, N. Harbeck, J. Dorn, B. Schmalfeldt, M. Schmitt, and E. P. Diamandis
Human Kallikrein 13 Protein in Ovarian Cancer Cytosols: A New Favorable Prognostic Marker
J. Clin. Oncol., February 15, 2004; 22(4): 678 - 685.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. M. Yousef, A. Scorilas, D. Katsaros, S. Fracchioli, L. Iskander, C. Borgono, I. A. Rigault de la Longrais, M. Puopolo, M. Massobrio, and E. P. Diamandis
Prognostic Value of the Human Kallikrein Gene 15 Expression in Ovarian Cancer
J. Clin. Oncol., August 15, 2003; 21(16): 3119 - 3126.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Kishi, L. Grass, A. Soosaipillai, A. Scorilas, N. Harbeck, B. Schmalfeldt, J. Dorn, M. Mysliwiec, M. Schmitt, and E. P. Diamandis
Human Kallikrein 8, a Novel Biomarker for Ovarian Carcinoma
Cancer Res., June 1, 2003; 63(11): 2771 - 2774.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Dong, A. Kaushal, M. Brattsand, J. Nicklin, and J. A. Clements
Differential Splicing of KLK5 and KLK7 in Epithelial Ovarian Cancer Produces Novel Variants with Potential as Cancer Biomarkers
Clin. Cancer Res., May 1, 2003; 9(5): 1710 - 1720.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. P. Diamandis, A. Scorilas, S. Fracchioli, M. van Gramberen, H. de Bruijn, A. Henrik, A. Soosaipillai, L. Grass, G. M. Yousef, U.-H. Stenman, et al.
Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma
J. Clin. Oncol., March 15, 2003; 21(6): 1035 - 1043.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Kishi, L. Grass, A. Soosaipillai, C. Shimizu-Okabe, and E. P. Diamandis
Human Kallikrein 8: Immunoassay Development and Identification in Tissue Extracts and Biological Fluids
Clin. Chem., January 1, 2003; 49(1): 87 - 96.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
C. D. Petraki, V. N. Karavana, L.-Y. Luo, and E. P. Diamandis
Human Kallikrein 10 Expression in Normal Tissues by Immunohistochemistry
J. Histochem. Cytochem., September 1, 2002; 50(9): 1247 - 1261.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
E. P. Diamandis and G. M. Yousef
Human Tissue Kallikreins: A Family of New Cancer Biomarkers
Clin. Chem., August 1, 2002; 48(8): 1198 - 1205.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. P. Diamandis, A. Okui, S. Mitsui, L.-Y. Luo, A. Soosaipillai, L. Grass, T. Nakamura, D. J. C. Howarth, and N. Yamaguchi
Human Kallikrein 11: A New Biomarker of Prostate and Ovarian Carcinoma
Cancer Res., January 1, 2002; 62(1): 295 - 300.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. M. Yousef, L. G. Kyriakopoulou, A. Scorilas, S. Fracchioli, B. Ghiringhello, M. Zarghooni, A. Chang, M. Diamandis, G. Giardina, W. J. Hartwick, et al.
Quantitative Expression of the Human Kallikrein Gene 9 (KLK9) in Ovarian Cancer: A New Independent and Favorable Prognostic Marker
Cancer Res., November 1, 2001; 61(21): 7811 - 7818.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L.-Y. Luo, D. Katsaros, A. Scorilas, S. Fracchioli, R. Piccinno, I. A. Rigault de la Longrais, D. J. C. Howarth, and E. P. Diamandis
Prognostic Value of Human Kallikrein 10 Expression in Epithelial Ovarian Carcinoma
Clin. Cancer Res., August 1, 2001; 7(8): 2372 - 2379.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.